The efficient spread of malaria from infected humans to mosquitoes is a major challenge for
malaria elimination initiatives. Gametocytes are the only Plasmodium life stage infectious to …

Malaria—a parasite vector-borne disease—is a global health problem, and Plasmodium
falciparum has proven to be the deadliest among Plasmodium spp., which causes malaria in …

Malaria is one of the most devastating human infectious diseases caused by Plasmodium
spp. parasites. A search for an effective and safe vaccine is the main challenge for its …

Plasmodium vivax (P. vivax) is the major malaria parasite outside of Africa and no vaccine is
available against it. A vaccine that interrupts parasite transmission (transmission-blocking …

New therapeutics are necessary for preventing Plasmodium vivax malaria due to easy
transmissibility and dormancy in the liver that increases the clinical burden due to recurrent …

Abstract “The Primate Malarias” book has been a uniquely important resource for multiple
generations of scientists, since its debut in 1971, and remains pertinent to the present day …

Introduction Plasmodium vivax causes significant public health problems in endemic
regions. A vaccine to prevent disease is critical, considering the rapid spread of drug …

Plasmodium vivax is one of the most geographically widespread malaria parasites in the
world, primarily found across South-East Asia, Latin America, and parts of Africa. One of the …

Interferon (IFN)-γ contributes to the pathogenesis of severe malaria; however, its mechanism
remains unclear. Herein, differences in IFN-γ levels between patients with severe and …

Existing control measures have significantly reduced malaria morbidity and mortality in the
last two decades, although these reductions are now stalling. Significant efforts have been …